Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, June 26, 2019

Tulane researcher awarded $2.4 million to study stem cell treatment for stroke

This moon shot is the best use of following the stroke strategy to get everyone 100% recovered? I don't think so.

But I'd rather they tackle known problems first. Like research that stops the 5 causes of the neuronal cascade of death in the first week. Much more likely to succeed. 

This crapola is why stroke survivors need to be in charge. Damn we need stroke leadership and we need it NOW. 

Tulane researcher awarded $2.4 million to study stem cell treatment for stroke

June 26, 2019 10:45 AM
 | 
Tulane Today staff today@tulane.edu
  
Print to PDF
Jean-Pyo Lee, PhD, assistant professor of physiology in the Tulane School of Medicine, was recently awarded a five-year, $2.4 million grant from the National Institute of Neurological Disorders and Stroke to study the effectiveness of neural stem cells in treating stroke. (Photo from School of Medicine)

Jean-Pyo Lee, PhD, assistant professor of physiology in the Tulane School of Medicine, was recently awarded a five-year, $2.4 million grant from the National Institute of Neurological Disorders and Stroke to study the use of neural stem cells in treating stroke.
Lee says that stem cell therapy potentially offers great promise in treating stroke, which is a leading cause of death in the United States. The only available drug approved by the U.S. Food and Drug Administration (FDA) for treatment of ischemic stroke (clots) is thrombolytic tissue plasminogen activator (tPA), which dissolves blood clots.
Procedures such as mechanical thrombectomy, during which a surgeon removes a blood clot by inserting a catheter into a blood vessel, restore blood flow but have a greater risk of destabilizing the blood-brain barrier, the vessel network protecting the brain from foreign substances in the blood.
Neural stem cells possess the ability to replace functional neurons and trigger anti-inflammatory actions which could improve recovery from acute stroke injury. Stem cell therapy currently targets stroke rehabilitation by delivering cells during the recovery (not acute) phase. New therapies are needed to lessen stroke’s detrimental effects and quickly facilitate vascular repair.
Lee’s project is aimed at investigating the beneficial role of early administration of stem cells in repairing blood vessels and brain tissue after stroke and improving long-term stroke recovery. To read more about Lee and her work, click here.
Posted by at
Labels: , , , , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)